Screening for ovarian cancer

Editorial

M J Webb. BMJ. 1993.

. 1993 Apr 17;306(6884):1015-6.

doi: 10.1136/bmj.306.6884.1015.

Erratum in

No abstract available

Screening for ovarian cancer. Still controversial, but encouraging.
Wald N, Parkes C. Wald N, et al. BMJ. 1993 Jun 19;306(6893):1684. doi: 10.1136/bmj.306.6893.1684. BMJ. 1993. PMID: 8324444 Free PMC article. No abstract available.
Screening for ovarian cancer. Multiple markers may outperform CA 125 alone.
Bast R, Woolas R. Bast R, et al. BMJ. 1993 Jun 19;306(6893):1684-5. doi: 10.1136/bmj.306.6893.1684-b. BMJ. 1993. PMID: 8324445 Free PMC article. No abstract available.

Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.
Bourne TH, Campbell S, Reynolds KM, Whitehead MI, Hampson J, Royston P, Crayford TJ, Collins WP. Bourne TH, et al. BMJ. 1993 Apr 17;306(6884):1025-9. doi: 10.1136/bmj.306.6884.1025. BMJ. 1993. PMID: 8490496 Free PMC article.
Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.
Jacobs I, Davies AP, Bridges J, Stabile I, Fay T, Lower A, Grudzinskas JG, Oram D. Jacobs I, et al. BMJ. 1993 Apr 17;306(6884):1030-4. doi: 10.1136/bmj.306.6884.1030. BMJ. 1993. PMID: 8490497 Free PMC article.